Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
54.5M
-
Shares change
-
+265K
-
Total reported value, excl. options
-
$1.92B
-
Value change
-
+$20.4M
-
Number of buys
-
83
-
Number of sells
-
-100
-
Price
-
$35.28
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2014
213 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q2 2014.
HAEMONETICS CORP - Common Stock (HAE) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.5M shares
.
Largest 10 shareholders include Neuberger Berman Group LLC (5.52M shares), VANGUARD GROUP INC (3.47M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (2.93M shares), BlackRock Fund Advisors (2.73M shares), FMR LLC (2.61M shares), WELLINGTON MANAGEMENT CO LLP (1.46M shares), BlackRock Institutional Trust Company, N.A. (1.4M shares), WESTWOOD HOLDINGS GROUP INC (1.35M shares), Van Berkom & Associates Inc. (1.35M shares), and PRUDENTIAL PLC (1.34M shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.